Ian A. Cook

Direttore Tecnico/Scientifico/R&S presso NeuroSigma, Inc.

64 anni

Consumer Services

Health Technology

Profilo

Ian A.
Cook is currently the Director of the Transcranial Magnetic Stimulation Service at the Semel Institute for Neuroscience & Human Behavior, Chief Medical Officer & Senior Vice President at NeuroSigma, Inc., Professor at the David Geffen School of Medicine, and Professor at the Henry Samueli School of Engineering & Applied Science.
He received his undergraduate degree from Princeton University and his doctorate from Yale School of Medicine.

Posizioni attive di Ian A. Cook

Società	Posizione	Inizio
NeuroSigma, Inc. NeuroSigma, Inc. Medical SpecialtiesHealth Technology NeuroSigma, Inc. operates as a life sciences company which develops bioelectronic technologies to treat major neurological and neuropsychiatric disorders such as epilepsy and depression. Its non-invasive external trigeminal nerve stimulation system (eTNS) employs trigeminal nerve stimulation, or TNS, as adjunctive therapy for drug-resistant epilepsy and major depressive disorder. The company was founded by Leon Ekchian in March 2008 and is headquartered in Los Angeles, CA.	Direttore Tecnico/Scientifico/R&S	01/01/2014
Henry Samueli School of Engineering & Applied Science	Corporate Officer/Principal	01/07/2013
David Geffen School of Medicine	Corporate Officer/Principal	01/07/2010
Semel Institute For Neuroscience & Human Behavior	Corporate Officer/Principal	01/01/2007

Tutte le posizioni attive di Ian A. Cook

Formazione di Ian A. Cook

Princeton University	Undergraduate Degree
Yale School of Medicine	Doctorate Degree

Esperienze
Posizioni ricoperte

Attive

Inattive

Società quotate in Borsa

Aziende private

Vedi nel dettaglio l'esperienza di Ian A. Cook

Relazioni

Relazioni di 1° grado

Aziende connesse in 1º grado

Uomo

Donna

Amministratori

Dirigenti

Vedi i contatti personali

Società collegate

Aziende private	1
NeuroSigma, Inc. NeuroSigma, Inc. Medical SpecialtiesHealth Technology NeuroSigma, Inc. operates as a life sciences company which develops bioelectronic technologies to treat major neurological and neuropsychiatric disorders such as epilepsy and depression. Its non-invasive external trigeminal nerve stimulation system (eTNS) employs trigeminal nerve stimulation, or TNS, as adjunctive therapy for drug-resistant epilepsy and major depressive disorder. The company was founded by Leon Ekchian in March 2008 and is headquartered in Los Angeles, CA.	Health Technology